You're all set! 🎉

Thanks for subscribing. Your plan is now active and every feature on it is unlocked. We've also sent a confirmation to your email.

Thanks for subscribing. Your plan is now active and every feature on it is unlocked. We've also sent a confirmation to your email.

MLTX

MoonLake Immunotherapeutics

Manufacturing

Pharmaceutical Products

XNAS

18.71

-1.38

-6.94%

Jul 28, 3:59 PM EDT

O 19.65H 19.65L 18.67C 18.71Vol 1.05M

Jul 28, 2026

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company. It is developing Sonelokimab,

Sector

Manufacturing

Theme

Unknown theme

Industry

Pharmaceutical Products

Date listed

Wed, Apr 06, 2022

Employees

Currency

usd

Shares outstanding

Locale

Shares float

Type

Market cap.

P/E (realtime)

Primary exchange

XNAS

CIK

0001821586

Website

No recent news for MLTX